search
Back to results

Manual vs Closed-loop Control of Mean Arterial Pressure

Primary Purpose

Hypotension

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
closed-loop system
Manual adjustment
Sponsored by
Erasme University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypotension

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • High-risk adult patients undergoing major abdominal surgeries requiring an advanced cardiac output monitoring device (EV1000-Edwards LifeSciences, Irvine, USA) and a tight blood pressure control

Exclusion Criteria:

  • Atrial Fibrillation
  • Severe Arythmia

Sites / Locations

  • Erasme Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

manual group

closed-loop group

Arm Description

Hypotension will be corrected by manual infusion of norepinephrine

Hypotension will be corrected by closed-loop control of norepinephrine infusion

Outcomes

Primary Outcome Measures

Percentage of case Time in hypotension (MAP < 90% of the chosen MAP target).
Undertreatment. Percentage of time during surgery in hypotension. The MAP used to define hypotension will differ for each patient (individualized approach)

Secondary Outcome Measures

Percentage of case time in hypotension (MAP < 65 mmHg)
Percentage of time during surgery in hypotension using the population target usually admitted and used in clinical studies (MAP < 65 mmHg)
Percentage of case time in target (MAP +/- 10 mmHg) of the chosen MAP target
Percentage of time during surgery with a MAP +/- 10 mmHg of the chosen MAP target.
Amount of vasopressors received
Amount of vasopressors received
Uretral perfusion index during surgery
Mean Uretral perfusion index during surgery using the novel IKORUS urinary catheter recently available on the market
Uretral perfusion index during the first 15 minutes of the surgery
Mean Uretral perfusion index during the first 15 minutes of the surgery
Uretral perfusion index during the last 15 minutes of the surgery
Mean Uretral perfusion index during the last 15 minutes of the surgery
Cardiac index during surgery
Mean cardiac index during surgery
Stroke volume index during surgery
Mean Stroke volume index during surgery
Stroke volume variation during surgery
Mean Stroke volume variation during surgery
Amount of fluid received during surgery
Amount of fluid received during surgery
Net fluid balance during surgery
Net fluid balance during surgery

Full Information

First Posted
September 12, 2019
Last Updated
March 6, 2020
Sponsor
Erasme University Hospital
Collaborators
University of California, Los Angeles, University of California, Irvine, Bicetre Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04089644
Brief Title
Manual vs Closed-loop Control of Mean Arterial Pressure
Official Title
Physician-Directed vs Computer-Assisted Norepinephrine Administration in Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
September 17, 2019 (Actual)
Primary Completion Date
March 5, 2020 (Actual)
Study Completion Date
March 5, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Erasme University Hospital
Collaborators
University of California, Los Angeles, University of California, Irvine, Bicetre Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Intraoperative hypotension can impact patient outcome. Vasopressors are usually used to correct hypotension and ensure adequate organ perfusion. The investigators have recently developed an automated system (closed-loop system) to titrate vasopressor agents in surgical and intensive care patients. The purpose of this study is to compare two strategies to correct hypotension based on an individual definition of hypotension (therefore, the target MAP used to define hypotension will differ for each patient (individualized approach): Control group = standard practice ( manually adjusted norepinephrine infusion to correct hypotension and keep MAP within 90% of patient's baseline MAP Intervention group = closed-loop (automated) vasopressor administration system will deliver norepinephrine using feedback from standard operating room hemodynamic monitor (EV1000 Monitor-Flotrac, Edwards Lifesciences, IRVINE, USA) to correct hypotension and keep MAP within 90% of patient's baseline MAP
Detailed Description
In order to prevent the known postoperative complications of intraoperative hypotension, vasopressor agents are occasionally used to ensure adequate perfusion. These vasopressors are usually administered as manually adjusted infusions, but this practice requires considerable time and attention. To overcome this issue, the investigators have developed a closed-loop vasopressor (CLV) controller to potentially correct hypotension more efficiently. After completing extensive in-silico, in-vivo studies and a pilot human trial in a small cohort of 20 patients, the investigators aimed to conduct now a randomized control trial comparing manual vasopressor adjustment versus closed-loop vasopressor adjustment in high risk patients undergoing major abdominal surgeries in order to correct hypotension during surgery The primary outcome will be the incidence of hypotension (defined as a reduction of > 10% from patient's MAP target, or a allowed tolerance of 10% reduction from patient's baseline MAP). This has been chosen based on the recent study of Emmanuel Futier and colleagues (Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017 Oct 10;318(14):1346-1357), even if it was originally done with systolic blood pressure Participants in both groups will receive standard patient care in that in no way will their anesthetic or surgical procedure will be altered as part of the study, with the exception of vasopressor administration. Fluids will be standardized in both groups and will be given as a continuous baseline infusion of 3 ml/kg/h (balanced crystalloid solution) and additional fluid boluses (mini fluid challenges of 100 ml) as a goal directed fluid therapy strategy to maintain stroke volume variation < 13%. The only difference is the way norepinephrine is delivered to the patient (manual versus closed-loop assisted)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Single center prospective randomized controlled trial
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
manual group
Arm Type
Active Comparator
Arm Description
Hypotension will be corrected by manual infusion of norepinephrine
Arm Title
closed-loop group
Arm Type
Experimental
Arm Description
Hypotension will be corrected by closed-loop control of norepinephrine infusion
Intervention Type
Device
Intervention Name(s)
closed-loop system
Intervention Description
Hypotension will be corrected by an automated system for vasopressor administration. Fluids will be given using a goal directed strategy (EV1000 Monitor, Edwards Lifesciences, Irvine, CA, USA)
Intervention Type
Device
Intervention Name(s)
Manual adjustment
Intervention Description
Vasopressor agents will be manually adjusted (standard practice). Fluids will be given using a goal directed strategy (EV1000 Monitor, Edwards Lifesciences, Irvine, CA, USA)
Primary Outcome Measure Information:
Title
Percentage of case Time in hypotension (MAP < 90% of the chosen MAP target).
Description
Undertreatment. Percentage of time during surgery in hypotension. The MAP used to define hypotension will differ for each patient (individualized approach)
Time Frame
At postoperative day 1
Secondary Outcome Measure Information:
Title
Percentage of case time in hypotension (MAP < 65 mmHg)
Description
Percentage of time during surgery in hypotension using the population target usually admitted and used in clinical studies (MAP < 65 mmHg)
Time Frame
during surgery
Title
Percentage of case time in target (MAP +/- 10 mmHg) of the chosen MAP target
Description
Percentage of time during surgery with a MAP +/- 10 mmHg of the chosen MAP target.
Time Frame
during surgery
Title
Amount of vasopressors received
Description
Amount of vasopressors received
Time Frame
during surgery
Title
Uretral perfusion index during surgery
Description
Mean Uretral perfusion index during surgery using the novel IKORUS urinary catheter recently available on the market
Time Frame
during surgery
Title
Uretral perfusion index during the first 15 minutes of the surgery
Description
Mean Uretral perfusion index during the first 15 minutes of the surgery
Time Frame
during surgery
Title
Uretral perfusion index during the last 15 minutes of the surgery
Description
Mean Uretral perfusion index during the last 15 minutes of the surgery
Time Frame
during surgery
Title
Cardiac index during surgery
Description
Mean cardiac index during surgery
Time Frame
during surgery
Title
Stroke volume index during surgery
Description
Mean Stroke volume index during surgery
Time Frame
during surgery
Title
Stroke volume variation during surgery
Description
Mean Stroke volume variation during surgery
Time Frame
during surgery
Title
Amount of fluid received during surgery
Description
Amount of fluid received during surgery
Time Frame
during surgery
Title
Net fluid balance during surgery
Description
Net fluid balance during surgery
Time Frame
during surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: High-risk adult patients undergoing major abdominal surgeries requiring an advanced cardiac output monitoring device (EV1000-Edwards LifeSciences, Irvine, USA) and a tight blood pressure control Exclusion Criteria: Atrial Fibrillation Severe Arythmia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alexandre Joosten, MD PhD
Organizational Affiliation
ERASME
Official's Role
Principal Investigator
Facility Information:
Facility Name
Erasme Hospital
City
Brussels
State/Province
Brussel-hoofdstad
ZIP/Postal Code
1070
Country
Belgium

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33041014
Citation
Joosten A, Chirnoaga D, Van der Linden P, Barvais L, Alexander B, Duranteau J, Vincent JL, Cannesson M, Rinehart J. Automated closed-loop versus manually controlled norepinephrine infusion in patients undergoing intermediate- to high-risk abdominal surgery: a randomised controlled trial. Br J Anaesth. 2021 Jan;126(1):210-218. doi: 10.1016/j.bja.2020.08.051. Epub 2020 Oct 8.
Results Reference
derived

Learn more about this trial

Manual vs Closed-loop Control of Mean Arterial Pressure

We'll reach out to this number within 24 hrs